top of page
OUR JOURNEY
Biomonadic started as an aspiration to enable scaling and greater patient access for cell and gene therapies, antibidoes, an industry that is the future of cures for cancer, aging, and a number of other diseases
OUR MISSION
Redefining manufacturing for cell culture bioprocesses
Our mission is to democratize access to lifesaving therapies, through leveraging AI to optimize the manufacturing process for these therapies, enabling their production at greater quality and speed and lower cost.

Vysak Venkateswaran
CEO
Vysak is a cancer immunologist turned engineer, AI/IoT product manager and biotech founder with experience building large scale architectures to optimize industrial manufacturing. Vysak began his career exploring T cell maturation in the context of cancer metastasis and built experience in the technology industry developing smart manufacturing platforms for the Fortune 100. Vysak is a multidisciplinary thinker and leader, with experience working in multiple industries (biotech, smart manufacturing, smart transit, energy, e-commerce) and has technical experience as a scientist and software engineer. Vysak studied biology and biotechnology at Duke and Northwestern and is currently pursuing his MBA at UC Berkeley.

Will Lunden
CTO
Will has a background in reinforcement learning and optimizing complex scientific architectures. Will worked on a small team to develop some of the world's first compact optical atomic clocks to be demonstrated outside of a laboratory environment. Running specialized deep learning-backed control software which he developed, these complex systems ran autonomously aboard an active naval vessel at sea for over 3 weeks. Will studied astronomy and physics at SUNY Stony Brook and received his PhD in atomic physics from MIT.
Our Journey So Far

bottom of page